- Office Hours
- Contact Us
Frequently asked questions about Intellectual Property Partners’ (IPP) Inventor Portal
In order to access the portal and submit a New Technology Disclosure (NTD), you must have a single sign on account (SSO) through Stony Brook University, and a Stony Brook email address (i.e., stonybrook.edu or stonybrookmedicine.edu). If you list additional email addresses such as your personal email address, please make sure that your Stony Brook University email address is selected as the primary email address. The only way to submit your NTD and receive emails pertaining to your disclosure is through your Stony Brook email address.
In order to access the portal and submit an NTD, your contact information must be current and only one record of your contact information can exist. Please check your profile on the left-hand side of the portal dashboard. Please update all contact and employment information accordingly. If you create a second profile or duplicate contact information, you will not be able to submit the disclosure.
If you selected Yes to question 1 entitled “Export Control Screening”, your invention disclosure cannot proceed. You will be contacted by the University’s export controls administration and security officer to obtain further information about your NTD before being able to complete the disclosure online.
Yes. You must identify all forms of funding that supported the research leading to your technology.
If federal funding supported your technology, you must select the “United States Government” as the funding source and provide the name of the government agency (e.g., NIH, NCI, NSF, DOE) as well as the complete grant information requested in the “Input Table for Grant Funding Information”. Specifically, the investigator holding the grant award, the grant number, the Research Foundation/SBU project/task/award number.
If non-federal funding supported your technology, you must select the appropriate funding source. For example, industry sponsored research, an Economic Development Center or Program such as CIEES/Energy CAT, the Center for Biotechnology, NYSERDA, Stony Brook Foundation, SUNY start-up funding to your laboratory or “other”.
If no outside funding supported your technology, please select “N/A: No Federal or Non-Federal Funding or other resources.
No, the order in which the inventors/creators are listed on an NTD is not significant. The order of inventors/creators will change based on which named inventor edited the disclosure last. The order that inventors are listed on a patent application may be determined separately at the time a patent application is applied for.
Yes. As long as you have a single sign on account (SSO) through Stony Brook University, and a Stony Brook email address (i.e., stonybrook.edu or stonybrookmedicine.edu).
A Research Reagent Disclosure should be submitted when your technology is a research tool. For example, an antibody, a cell line, mouse model or other material. To complete a Research Reagent disclosure please select “Research Reagent Disclosure” from the drop-down list for the “Type of Disclosure” in the Inventor Portal. When prompted please fill out all of the information in category 6 – “Description of Research Tool” as well as any other pertinent information.
A New Invention Disclosure should be submitted when your technology has commercial applicability beyond that of a research reagent or tool. For example, software, a chemical composition, technology, a new device, a method of treating a patient, or a system. To complete a New Invention Disclosure please select “New Invention Disclosure” from the drop-down list for the “Type of Disclosure” in the Inventor Portal. When prompted please fill out all of the information requested in the portal.
Intellectual Property Partners has changed the default settings on the inventor portal, so that all named Stony Brook University inventors will automatically have edit rights to a draft disclosure. Please note that all editors may access the draft disclosure and make changes simultaneously. So, please be sure to check all final draft disclosures: 1) before final submission and 2) upon signature.
If you see an error, please do not sign the disclosure. Please call IPP at 631-632-9009 or email firstname.lastname@example.org. IPP will revert the disclosure to draft form so that any necessary corrections can be made.